In pancreatic cancer, MME+ CAFs exhibit heightened glycolytic activity, increasing tumor burden by recruiting neutrophils and Tregs while suppressing CD8+ T, NK, and DC cell infiltration, thus fostering an immunosuppressive environment that impairs immunotherapy effect [213]. The gene discussed is CD8A; the disease is neoplasm.